Xiaoqi He

880 total citations
34 papers, 579 citations indexed

About

Xiaoqi He is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiaoqi He has authored 34 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Xiaoqi He's work include Endometrial and Cervical Cancer Treatments (6 papers), RNA modifications and cancer (5 papers) and RNA Interference and Gene Delivery (4 papers). Xiaoqi He is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), RNA modifications and cancer (5 papers) and RNA Interference and Gene Delivery (4 papers). Xiaoqi He collaborates with scholars based in China, Macao and Hungary. Xiaoqi He's co-authors include Zehua Wang, Jing Cai, Jizhou Wang, Ye Yuan, Weijie Du, Gege Yan, Lei Yang, Si Sun, Lei Hong and Yang Wang and has published in prestigious journals such as Journal of Hazardous Materials, Soil Biology and Biochemistry and Science Advances.

In The Last Decade

Xiaoqi He

32 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoqi He China 14 353 222 98 91 57 34 579
Quan Wan China 14 250 0.7× 183 0.8× 77 0.8× 97 1.1× 78 1.4× 33 509
Jihong Ma China 12 306 0.9× 134 0.6× 74 0.8× 97 1.1× 35 0.6× 24 575
Xiaohu Fan Canada 13 223 0.6× 161 0.7× 166 1.7× 87 1.0× 37 0.6× 18 596
Xigan He China 12 459 1.3× 327 1.5× 106 1.1× 125 1.4× 27 0.5× 28 706
Jianming Huang China 13 211 0.6× 128 0.6× 54 0.6× 106 1.2× 37 0.6× 41 450
May Truongcao United States 11 441 1.2× 187 0.8× 65 0.7× 109 1.2× 19 0.3× 18 662
Hellen Kuasne Brazil 14 323 0.9× 107 0.5× 111 1.1× 157 1.7× 33 0.6× 24 615
Haoyue Hu China 11 251 0.7× 140 0.6× 66 0.7× 163 1.8× 42 0.7× 31 524
Miaoyun Long China 14 239 0.7× 166 0.7× 80 0.8× 61 0.7× 25 0.4× 37 451
Xiyi Lu China 16 789 2.2× 693 3.1× 57 0.6× 65 0.7× 56 1.0× 29 1.0k

Countries citing papers authored by Xiaoqi He

Since Specialization
Citations

This map shows the geographic impact of Xiaoqi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoqi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoqi He more than expected).

Fields of papers citing papers by Xiaoqi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoqi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoqi He. The network helps show where Xiaoqi He may publish in the future.

Co-authorship network of co-authors of Xiaoqi He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoqi He. A scholar is included among the top collaborators of Xiaoqi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoqi He. Xiaoqi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Xuemei, Lu Deng, Xiaoqi He, et al.. (2025). RBC Membrane‐Camouflaged Nanosystem‐Mediated Synergistic Drug Combination for Enhanced Anti‐Tumor Therapy. Advanced Healthcare Materials. 14(26). e2500446–e2500446. 2 indexed citations
2.
Hu, Chuan, Xiaoqi He, Huile Gao, & Jinming Zhang. (2025). DELIVER: The core principles for the clinic translation of nanomedicines. Acta Pharmaceutica Sinica B. 15(2). 1196–1198. 2 indexed citations
3.
Gao, Na, Xiaofan Na, Haowei Sun, et al.. (2025). UV-B stress reshapes root-associated microbial communities and networks, driven by host plant resistance. Soil Biology and Biochemistry. 205. 109767–109767. 2 indexed citations
4.
5.
Wang, Shengwang, Xiaofan Na, Junjie Li, et al.. (2024). The monokaryotic filamentous fungus Ustilago sp. HFJ311 promotes plant growth and reduces Cd accumulation by enhancing Fe transportation and auxin biosynthesis. Journal of Hazardous Materials. 477. 135423–135423. 1 indexed citations
6.
He, Mingyu, Gege Yan, Yang Wang, et al.. (2021). Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR. Journal of Cellular and Molecular Medicine. 25(11). 4962–4973. 11 indexed citations
7.
Yuan, Ye, Gege Yan, Mingyu He, et al.. (2021). ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma. Cell Death and Disease. 12(1). 60–60. 89 indexed citations
8.
Wu, Min, Yanan Yang, Yuhui Huang, et al.. (2021). Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma. Current Medical Science. 42(1). 185–191. 6 indexed citations
9.
Yang, Qiang, Qing-Hui Zhou, Xiaoqi He, et al.. (2021). Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer. Journal of Gynecology Obstetrics and Human Reproduction. 50(8). 102145–102145. 5 indexed citations
10.
Li, Guoqing, Xiaohan Xu, Jing Cai, et al.. (2021). FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer. Cancer Cell International. 21(1). 568–568. 22 indexed citations
11.
Cai, Jing, Xiaoqi He, Hongbo Wang, et al.. (2021). Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes. Radiation Oncology. 16(1). 54–54. 12 indexed citations
12.
Jiang, Jiahong, Shaohai Wang, Zehua Wang, et al.. (2020). HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer. Cancer Chemotherapy and Pharmacology. 86(2). 295–305. 23 indexed citations
13.
He, Xiaoqi, et al.. (2020). Metabolic syndrome increases risk for perioperative outcomes following posterior lumbar interbody fusion. Medicine. 99(38). e21786–e21786. 8 indexed citations
14.
Yan, Gege, Lei Hong, Mingyu He, et al.. (2020). Melatonin triggers autophagic cell death by regulating RORC in Hodgkin lymphoma. Biomedicine & Pharmacotherapy. 123. 109811–109811. 14 indexed citations
15.
Wang, Jizhou, et al.. (2018). Impact of different laminae open angles on axial symptoms after expansive open-door laminoplasty. Medicine. 97(32). e11823–e11823. 2 indexed citations
16.
Meng, Qingliang, et al.. (2017). MEK inhibitor enhances sensitivity to chemotherapeutic drugs in multidrug resistant hepatocellular carcinoma cells. Oncology Letters. 14(3). 3089–3095. 4 indexed citations
17.
He, Xiaoqi, et al.. (2015). RhoC is essential in TGF-β1 induced epithelial-mesenchymal transition in cervical cancer cells. Oncology Letters. 10(2). 985–989. 9 indexed citations
18.
Zhang, Jinnong, et al.. (2013). Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis. Irish Journal of Medical Science (1971 -). 183(4). 557–564. 19 indexed citations
19.
He, Xiaoqi, et al.. (2011). Effect of downregulated β-catenin on cell proliferative activity, the sensitivity to chemotherapy drug and tumorigenicity of ovarian cancer cells.. PubMed. 57 Suppl. OL1606–13. 15 indexed citations
20.
He, Xiaoqi, et al.. (2008). The effect of RhoC siRNA on the invasiveness and proliferation of human cervical cancer cell line SiHa cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(6). 665–669. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quan Wan Breakdown of academic impact, for papers by Jihong Ma Breakdown of academic impact, for papers by Xiaohu Fan Breakdown of academic impact, for papers by Xigan He Breakdown of academic impact, for papers by Jianming Huang Breakdown of academic impact, for papers by May Truongcao Breakdown of academic impact, for papers by Hellen Kuasne Breakdown of academic impact, for papers by Haoyue Hu Breakdown of academic impact, for papers by Miaoyun Long Breakdown of academic impact, for papers by Xiyi Lu
Rankless by CCL
2026